CDD-1733 structure
|
Common Name | CDD-1733 | ||
|---|---|---|---|---|
| CAS Number | 2894104-33-5 | Molecular Weight | 599.65 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C34H32F3N5O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CDD-1733CDD-1733 is a non-covalent and non-peptide potent SARS-CoV-2 Mpro inhibitor with a Ki of 12 nM. CDD-1733 also inhibits ΔP168, A173V, and ΔP168/A173V Mpro variants[1]. |
| Name | CDD-1733 |
|---|
| Description | CDD-1733 is a non-covalent and non-peptide potent SARS-CoV-2 Mpro inhibitor with a Ki of 12 nM. CDD-1733 also inhibits ΔP168, A173V, and ΔP168/A173V Mpro variants[1]. |
|---|---|
| Related Catalog | |
| Target |
Ki: 12 nM (SARS-CoV-2 Mpro)[1] |
| References |
| Molecular Formula | C34H32F3N5O2 |
|---|---|
| Molecular Weight | 599.65 |
| InChIKey | FOWCQWSLGBHNCT-WWGLSMKPSA-N |
| SMILES | CCCC(NC(=O)c1cccc2nc(-c3cncc4ccccc34)n(C3CC(C(=O)NC)C3)c12)c1ccc(C(F)(F)F)cc1 |